BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22465996)

  • 1. Nkx3.1 functions as para-transcription factor to regulate gene expression and cell proliferation in non-cell autonomous manner.
    Zhou J; Qin L; Tien JC; Gao L; Chen X; Wang F; Hsieh JT; Xu J
    J Biol Chem; 2012 May; 287(21):17248-17256. PubMed ID: 22465996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.
    Rao V; Guan B; Mutton LN; Bieberich CJ
    J Biol Chem; 2012 Oct; 287(43):36331-40. PubMed ID: 22910912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
    Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
    PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
    Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
    Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.
    Dutta A; Panja S; Virk RK; Kim JY; Zott R; Cremers S; Golombos DM; Liu D; Mosquera JM; Mostaghel EA; Barbieri CE; Mitrofanova A; Abate-Shen C
    Eur Urol; 2017 Oct; 72(4):499-506. PubMed ID: 28385453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor.
    Ju JH; Maeng JS; Zemedkun M; Ahronovitz N; Mack JW; Ferretti JA; Gelmann EP; Gruschus JM
    J Mol Biol; 2006 Jul; 360(5):989-99. PubMed ID: 16814806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.
    Padmanabhan A; Gosc EB; Bieberich CJ
    J Cell Biochem; 2013 May; 114(5):1050-7. PubMed ID: 23129228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
    Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
    Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
    Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
    J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
    Bowen C; Ostrowski MC; Leone G; Gelmann EP
    Cancer Res; 2019 Aug; 79(16):4124-4134. PubMed ID: 31213464
    [No Abstract]   [Full Text] [Related]  

  • 11. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
    Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
    Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effects of NKX3.1 on IGF-1R expression and its signalling pathway in human prostatic carcinoma PC3 cells.
    Zhang PJ; Hu XY; Liu CY; Chen ZB; Ni NN; Yu Y; Yang LN; Huang ZQ; Liu QW; Jiang AL
    Asian J Androl; 2012 May; 14(3):493-8. PubMed ID: 22179513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAMP1 is a direct NKX3.1 target gene up-regulated in prostate cancer that promotes tumorigenesis.
    Logan M; Anderson PD; Saab ST; Hameed O; Abdulkadir SA
    Am J Pathol; 2013 Sep; 183(3):951-63. PubMed ID: 23867798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant treatment promotes prostate epithelial proliferation in Nkx3.1 mutant mice.
    Martinez EE; Anderson PD; Logan M; Abdulkadir SA
    PLoS One; 2012; 7(10):e46792. PubMed ID: 23077524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKX3.1 activates expression of insulin-like growth factor binding protein-3 to mediate insulin-like growth factor-I signaling and cell proliferation.
    Muhlbradt E; Asatiani E; Ortner E; Wang A; Gelmann EP
    Cancer Res; 2009 Mar; 69(6):2615-22. PubMed ID: 19258508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of Nkx3.1 and p27kip1 in prostate tumor initiation.
    Gary B; Azuero R; Mohanty GS; Bell WC; Eltoum IE; Abdulkadir SA
    Am J Pathol; 2004 May; 164(5):1607-14. PubMed ID: 15111307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis.
    Fonseca-Alves CE; Rodrigues MM; de Moura VM; Rogatto SR; Laufer-Amorim R
    Microsc Res Tech; 2013 Dec; 76(12):1250-6. PubMed ID: 24030851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.
    Asatiani E; Huang WX; Wang A; Rodriguez Ortner E; Cavalli LR; Haddad BR; Gelmann EP
    Cancer Res; 2005 Feb; 65(4):1164-73. PubMed ID: 15734999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis.
    Anderson PD; McKissic SA; Logan M; Roh M; Franco OE; Wang J; Doubinskaia I; van der Meer R; Hayward SW; Eischen CM; Eltoum IE; Abdulkadir SA
    J Clin Invest; 2012 May; 122(5):1907-19. PubMed ID: 22484818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.